{
  "retracted": false,
  "timestamp": 1444348800000,
  "updates": [
    {
      "timestamp": 1496036657117,
      "identifier": {
        "doi": "10.1371/journal.pone.0140623"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1371/journal.pone.0118228"
  },
  "journal": "PLOS ONE",
  "publisher": "Public Library of Science (PLoS)",
  "title": "Correction: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection"
}
